These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 12419309

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Calpain-mediated cleavage of the cyclin-dependent kinase-5 activator p39 to p29.
    Patzke H, Tsai LH.
    J Biol Chem; 2002 Mar 08; 277(10):8054-60. PubMed ID: 11784720
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. p35/Cdk5 pathway mediates soluble amyloid-beta peptide-induced tau phosphorylation in vitro.
    Town T, Zolton J, Shaffner R, Schnell B, Crescentini R, Wu Y, Zeng J, DelleDonne A, Obregon D, Tan J, Mullan M.
    J Neurosci Res; 2002 Aug 01; 69(3):362-72. PubMed ID: 12125077
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The levels of cdk5 and p35 proteins and tau phosphorylation are reduced during neuronal apoptosis.
    Kerokoski P, Suuronen T, Salminen A, Soininen H, Pirttilä T.
    Biochem Biophys Res Commun; 2001 Feb 02; 280(4):998-1002. PubMed ID: 11162625
    [Abstract] [Full Text] [Related]

  • 9. Involvement of calpain and p25 of CDK5 pathway in ginsenoside Rb1's attenuation of beta-amyloid peptide25-35-induced tau hyperphosphorylation in cortical neurons.
    Chen X, Huang T, Zhang J, Song J, Chen L, Zhu Y.
    Brain Res; 2008 Mar 20; 1200():99-106. PubMed ID: 18289510
    [Abstract] [Full Text] [Related]

  • 10. A 24-residue peptide (p5), derived from p35, the Cdk5 neuronal activator, specifically inhibits Cdk5-p25 hyperactivity and tau hyperphosphorylation.
    Zheng YL, Amin ND, Hu YF, Rudrabhatla P, Shukla V, Kanungo J, Kesavapany S, Grant P, Albers W, Pant HC.
    J Biol Chem; 2010 Oct 29; 285(44):34202-12. PubMed ID: 20720012
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Stabilization of the cyclin-dependent kinase 5 activator, p35, by paclitaxel decreases beta-amyloid toxicity in cortical neurons.
    Li G, Faibushevich A, Turunen BJ, Yoon SO, Georg G, Michaelis ML, Dobrowsky RT.
    J Neurochem; 2003 Jan 29; 84(2):347-62. PubMed ID: 12558997
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Glutamate treatment and p25 transfection increase Cdk5 mediated tau phosphorylation in SH-SY5Y cells.
    Jämsä A, Bäckström A, Gustafsson E, Dehvari N, Hiller G, Cowburn RF, Vasänge M.
    Biochem Biophys Res Commun; 2006 Jun 23; 345(1):324-31. PubMed ID: 16678793
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles.
    Cruz JC, Tseng HC, Goldman JA, Shih H, Tsai LH.
    Neuron; 2003 Oct 30; 40(3):471-83. PubMed ID: 14642273
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.